News
Medical technology company Becton, Dickinson and Company (NYSE:BDX) met Wall Street’s revenue expectations in Q2 CY2025, with ...
Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be reporting earnings this Thursday before the bell.
5d
Zacks Investment Research on MSNCan Sustained Product Demand Drive BDX Stock Before Q3 Earnings?Becton Dickinson and Company BDX, popularly known as BD, is scheduled to report third-quarter fiscal 2025 results on Aug. 7, ...
BD (NYSE: BDX) shares ticked up before hours today on third-quarter results that came in ahead of the consensus Wall Street ...
4d
Zacks Investment Research on MSNBecton Dickinson (BDX) Surpasses Q3 Earnings and Revenue EstimatesBecton Dickinson (BDX) came out with quarterly earnings of $3.68 per share, beating the Zacks Consensus Estimate of $3.42 per share. This compares to earnings of $3.5 per share a year ago. These ...
Becton, Dickinson (BDX) stock gains as the company boosts fiscal 2025 earnings outlook after better than expected Q3 results.
3d
Zacks.com on MSNBD Stock Gains in Pre-Market Following Q3 Earnings Beat, Margins UpDetailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.
Becton Dickinson beat Q3 earnings and revenue estimates, raised its FY25 EPS outlook, and saw strong growth in its medical ...
The stock's rise snapped a five-day losing streak.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results